Supercritical Fluid Extraction of Fucoxanthin from the Diatom Phaeodactylum tricornutum and Biogas Production through Anaerobic Digestion

Elucidating supercritical fluid extraction of fucoxanthin from algae to enable the integrated biorefinery

The emerging nutraceutical, fucoxanthin, shows promise as a high-value product to enable the integrated biorefinery. Fucoxanthin can be extracted from algae through supercritical fluid extraction (SFE), but literature does not agree on optimal extraction conditions. Here, a statistical analysis of literature identifies supercritical carbon dioxide (scCO2) density, ethanol cosolvent amount, and polarity as significant predictors of fucoxanthin yield. Novel SFE experiments are then performed using a fucoxanthin standard, describing its fundamental solubility. These experiments establish solvent system polarity as the key knob to tune fucoxanthin recovery from 0% to 100% and give specific operating conditions for targeted fucoxanthin extraction.Further experiments compare extractions on fucoxanthin standard with extractions from Phaeodactylum tricornutum microalgae to elucidate the effect of the algae matrix. Results show selectivity of fucoxanthin over chlorophyll in scCO2 microalgae extractions that was not seen in extractions with ethanol, indicating a benefit of scCO2 to design selective extraction schemes.

From nature's bounty to drug discovery: Leveraging phytochemicals and molecular approaches to combat multi-drug-resistant (MDR) tuberculosis

A large number of people annually lose their lives to tuberculosis (TB), which is an age-old disease caused by the Mycobacterium tuberculosis. The global spread of TB is a concern for all regions. The south-east Asian region recorded 46% of all new TB cases in 2021, followed by the African and western Pacific regions with 23% and 18%, respectively. Researchers are always searching at natural substances for potential alternative therapeutics to tackle the worrisome growth in multi-drug-resistant (MDR) tuberculosis due to the high costs associated with developing new treatments and unfavourable side effects of currently used synthetic pharmaceuticals. Phytochemicals show promising results as a future health aid due to their multi-targeting ability on pathogen cells. In the search for new drug leads, the Ayurvedic and Siddha medical systems have made an extensive use of ethnomedicinal tools, including the use of plants like Amalaki (Emblica officinalis Gaertn.), Guduchi (Tinospora cordifolia willd.), Sariva (Hemidesmus indicus R.Br.), Kustha (Saussurea lappa Falc.), turmeric (Curcuma longa Mal.) and Green tea (Camellia sinensis Linn.). These sources are high in flavonoids, polyphenols, tannins and catechins, has been shown to reduce the risk of TB. In this overview, we look at how natural sources like plants, algae and mushrooms have helped researchers to find new drug leads, and how to back these natural sources through mapping the molecular approaches and other approaches has helped them to defeat MDR.

Advances in fucoxanthin chemistry and management of neurodegenerative diseases

BACKGROUND

Neurodegenerative diseases are chronic, currently incurable, diseases of the elderly, which are characterized by protein misfolding and neuronal damage. Fucoxanthin, derived from marine brown algae, presents a promising candidate for the development of effective therapeutic strategies.

HYPOTHESIS AND PURPOSE

The relationship between neurodegenerative disease management and fucoxanthin has not yet been clarified. This study focuses on the fundamental mechanisms and targets of fucoxanthin in Alzheimer's and Parkinson's disease management, showing that communication between the brain and the gut contributes to neurodegenerative diseases and early diagnosis of ophthalmic diseases. This paper also presents, new insights for future therapeutic directions based on the integrated application of artificial intelligence.

CONCLUSION

Fucoxanthin primarily binds to amyloid fibrils with spreading properties such as Aβ, tau, and α-synuclein to reduce their accumulation levels, alleviate inflammatory factors, and restore mitochondrial membranes to prevent oxidative stress via Nrf2 and Akt signaling pathways, involving reduction of specific secretases. In addition, fucoxanthin may serve as a preventive diagnosis for neurodegenerative diseases through ophthalmic disorders. It can modulate gut microbes and has potential for the alleviation and treatment of neurodegenerative diseases.

High-Purity Fucoxanthin Can Be Efficiently Prepared from Isochrysis zhangjiangensis by Ethanol-Based Green Method Coupled with Octadecylsilyl (ODS) Column Chromatography

The exploitation of new economically valuable microalgae as a sustainable source of minor high-value products can effectively promote the full utilization of microalgae. The efficient preparation of minor products from microalgae remains the challenge, owing to the coexistence of various components with a similar polarity in the microalgae biomass. In this study, a novel approach based on the sustainable-oriented strategy for fucoxanthin (FX) production was proposed, which consisted of four steps, including the culture of microalga, ethanol extraction, ODS column chromatography, and ethanol precipitation. The high-purity FX (around 95%) was efficiently obtained in a total recovery efficiency of 84.28 ± 2.56%. This study reveals that I. zhangjiangensis is a potentially promising feedstock for FX production and firstly provides a potentially eco-friendly method for the scale-up preparation of FX from the microalga I. zhangjiangensis.

Diatoms as a biotechnological resource for the sustainable biofuel production: a state-of-the-art review

The greenhouse gas emission from fossil fuel and higher economic cost in its transportation are stimulating scientists to explore biomass energy production at the local level. In the present review, the authors have explored the prospects of commercial-scale biofuels production from the microalgal group, diatoms. Insights on suitability of mass cultivation systems for large-scale production of diatoms have been deliberated based on published literature. Diatoms can proliferate extracting nutrients from the wastewater and the same biomass can be harvested for biofuel production. Residues can be further utilized for the formation of other bioproducts and biofertilizers. The residual applications of diatoms from mass culture are estimated to compensate for the additional costs incurred in the removal of impurities. Well-planned research is required to optimize the commercial-scale production of biofuels from diatoms. The aim of this review is therefore, to demonstrate the economically feasible, hygienically safe cultivation of diatoms on nutrients from wastewater, limitations in using diatoms for biofuel production, and how these limitations can be shorted out for optimum utilization of diatom for biofuel production.

Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes

Fucoxanthin is a brown-colored pigment from algae, with great potential as a bioactive molecule due to its numerous properties. This review aims to present current knowledge on this high added-value pigment. An accurate analysis of the biological function of fucoxanthin explains its wide photon absorption capacities in golden-brown algae. The specific chemical structure of this pigment also leads to many functional activities in human health. They are outlined in this work and are supported by the latest studies in the literature. The scientific and industrial interest in fucoxanthin is correlated with great improvements in the development of algae cultures and downstream processes. The best fucoxanthin producing algae and their associated culture parameters are described. The light intensity is a major influencing factor, as it has to enable both a high biomass growth and a high fucoxanthin content. This review also insists on the most eco-friendly and innovative extraction methods and their perspective within the next years. The use of bio-based solvents, aqueous two-phase systems and the centrifugal partition chromatography are the most promising processes. The analysis of the global market and multiple applications of fucoxanthin revealed that Asian companies are major actors in the market with macroalgae. In addition, fucoxanthin from microalgae are currently produced in Israel and France, and are mostly authorized in the USA.